Can anamorelin improve the quality of life of cancer patients?

The quality of life of cancer patients is affected by many factors, including symptoms caused by the disease itself, side effects of treatment, psychological stress and nutritional status. In cancer cachexia, weight loss, muscle loss and severe fatigue often lead to reduced functional ability and limited self-care ability of patients, thus significantly affecting the quality of life. Anamorelin improves appetite, weight and muscle mass by activating ghrelin receptors, helping to improve the patient's overall experience and functional status in multiple dimensions.

Studies have shown that Anamorelin can increase patients' interest in eating and food intake in a short period of time, thereby promoting weight recovery and indirectly enhancing physical strength and daily activity capabilities. This is especially important for patients who are bedridden or have limited mobility for a long time. It can help them regain basic self-care abilities and reduce their dependence on family and medical resources. In practical applications, some patients reported that their emotional state improved after using anamulin, which may be related to the normalization of eating behavior and recovery of physical fitness, and also suggests the potential benefits of this drug in mental health.

The improvement in quality of life is not only reflected at the physical level, but also includes patients' sense of control over their condition. The positive changes brought about by anamorelin may increase patients' confidence and sense of hope in treatment, thereby promoting better treatment compliance. In multiple patient-reported outcome studies, the anamorelin treatment group was superior to the control group in terms of physical status scores (such asKPS or ECOG scores) and subjective well-being. Although this result still needs to be further confirmed by larger studies, there is evidence to support its potential to improve quality of life.

In short, anamorelin not only improves the core symptoms of cancer cachexia as a metabolic support drug, but also comprehensively improves the patient's quality of life by enhancing nutritional status, improving physical strength and mental state, and provides a new auxiliary treatment method for the full management of cancer.

Reference materials:https://pmc.ncbi.nlm.nih.gov/articles/PMC4677053/